Xiao-Fei Kong, M.D., Ph.D. Titles and Appointments Assistant Professor Schools Medical School | Graduate School Departments Internal Medicine | Eugene McDermott Center for Human Growth and Development Graduate Programs Immunology You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Xiao-Fei Kong, M.D., Ph.D., is an Assistant Professor in the Department of Internal Medicine and the Eugene McDermott Center for Human Growth and Development at UT Southwestern Medical Center. Also, he is a member of the Division of Digestive & Liver Diseases. Originally from China, Dr. Kong earned his medical degree at Yangzhou University Medical College in Jiangsu, China, and completed a residency in internal medicine at Ruijin Hospital at Shanghai Jiaotong University. He then earned a doctoral degree in immunology and genetics from the Sorbonne University in Paris, France. He later earned a master's degree in translational medicine from the Rockefeller University in New York. He received additional internal medicine residency training at the Icahn School of Medicine at Mount Sinai, followed by advanced training through a fellowship in gastroenterology at Columbia University Irving Medical Center. Certified by the American Board of Internal Medicine in internal medicine and gastroenterology, he joined the UT Southwestern faculty in 2022. Dr. Kong's clinical interests include Crohn's disease and ulcerative colitis, celiac disease, complex gastrointestinal disorders, immune dysregulation, and inborn errors of immunity. He has a particular interest in caring for patients with severe, atypical, or difficult-to-manage gastrointestinal conditions, including recurrent intestinal inflammation and immune dysregulation. He combines expertise in clinical gastroenterology, human genetics, and immunology to provide individualized care and investigate the underlying causes of complex diseases. Dr. Kong leads a research program focused on understanding the molecular mechanisms of inflammation, infection, and autoimmunity. He has received multiple NIH research grants to investigate celiac disease, autoimmune hepatitis, and immune-mediated gastrointestinal disorders. His research integrates human genomics, immunology, molecular biology, and large-scale biomedical data to identify genetic risk factors, uncover disease mechanisms, and develop more precise approaches to diagnosis, risk stratification, and treatment. His previous work has led to the discovery of several genetic diseases, including human SPPL2A deficiency, inherited STAT1 disorders, and interferonopathy in Down syndrome. He has published numerous articles in peer-reviewed journals and presented his research at national and international conferences. Dr. Kong is an active member of several professional organizations, including the American Association for the Study of Liver Diseases, the American Gastroenterological Association, and the European Society for Immunodeficiencies. Education Medical Education Yangzhou University Medical College (2001), Bachelor of Medicine/Surgery Residency Icahn School of Medicine at Mount Sinai /Queens Hospital Center (2018), Internal Medicine Fellowship Columbia University - New York Presbyterian Hospital (2021), Gastroenterology Research Interest Celiac Disease Human Genetics Immunology Inflammatory Bowel Disease Rare Digestive & Liver Diseases Publications Featured Publications Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome. Kong XF, Worley L, Rinchai D, Bondet V, Jithesh PV, Goulet M, Nonnotte E, Rebillat AS, Conte M, Mircher C, Gürtler N, Liu L, Migaud M, Elanbari M, Habib T, Ma CS, Bustamante J, Abel L, Ravel A, Lyonnet S, Munnich A, Duffy D, Chaussabel D, Casanova JL, Tangye SG, Boisson-Dupuis S, Puel A, J. Clin. Immunol. 2020 Jun Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Kong XF, Martinez-Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick EK, Ma CS, Breton G, Lucero KB, Langlais D, Bousfiha A, Aytekin C, Markle J, Trouillet C, Jabot-Hanin F, Arlehamn CSL, Rao G, Picard C, Lasseau T, Latorre D, Hambleton S, Deswarte C, Itan Y, Abarca K, Moraes-Vasconcelos D, Ailal F, Ikinciogullari A, Dogu F, Benhsaien I, Sette A, Abel L, Boisson-Dupuis S, Schröder B, Nussenzweig MC, Liu K, Geissmann F, Tangye SG, Gros P, Sallusto F, Bustamante J, Casanova JL, Nat Immunol 2018 09 19 9 973-985 Haploinsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Kong XF, Vogt G, Itan Y, Macura-Biegun A, Szaflarska A, Kowalczyk D, Chapgier A, Abhyankar A, Furthner D, Djambas Khayat C, Okada S, Bryant VL, Bogunovic D, Kreins A, Moncada-Vélez M, Migaud M, Al-Ajaji S, Al-Muhsen S, Holland SM, Abel L, Picard C, Chaussabel D, Bustamante J, Casanova JL, Boisson-Dupuis S, Hum Mol Genet 2013 Feb 22 4 769-81 Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes. Boisson-Dupuis S, Kong XF, Okada S, Cypowyj S, Puel A, Abel L, Casanova JL, Curr Opin Immunol 2012 Aug 24 4 364-78 Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. Liu L, Okada S, Kong XF, Kreins AY, Cypowyj S, Abhyankar A, Toubiana J, Itan Y, Audry M, Nitschke P, Masson C, Toth B, Flatot J, Migaud M, Chrabieh M, Kochetkov T, Bolze A, Borghesi A, Toulon A, Hiller J, Eyerich S, Eyerich K, Gulácsy V, Chernyshova L, Chernyshov V, Bondarenko A, Grimaldo RM, Blancas-Galicia L, Beas IM, Roesler J, Magdorf K, Engelhard D, Thumerelle C, Burgel PR, Hoernes M, Drexel B, Seger R, Kusuma T, Jansson AF, Sawalle-Belohradsky J, Belohradsky B, Jouanguy E, Bustamante J, Bué M, Karin N, Wildbaum G, Bodemer C, Lortholary O, Fischer A, Blanche S, Al-Muhsen S, Reichenbach J, Kobayashi M, Rosales FE, Lozano CT, Kilic SS, Oleastro M, Etzioni A, Traidl-Hoffmann C, Renner ED, Abel L, Picard C, Maródi L, Boisson-Dupuis S, Puel A, Casanova JL, J Exp Med 2011 Aug 208 8 1635-48 A novel form of human STAT1 deficiency impairing early but not late responses to interferons. Kong XF, Ciancanelli M, Al-Hajjar S, Alsina L, Zumwalt T, Bustamante J, Feinberg J, Audry M, Prando C, Bryant V, Kreins A, Bogunovic D, Halwani R, Zhang XX, Abel L, Chaussabel D, Al-Muhsen S, Casanova JL, Boisson-Dupuis S, Blood 2010 Dec 116 26 5895-906 A novel form of cell type-specific partial IFN-gammaR1 deficiency caused by a germ line mutation of the IFNGR1 initiation codon. Kong XF, Vogt G, Chapgier A, Lamaze C, Bustamante J, Prando C, Fortin A, Puel A, Feinberg J, Zhang XX, Gonnord P, Pihkala-Saarinen UM, Arola M, Moilanen P, Abel L, Korppi M, Boisson-Dupuis S, Casanova JL, Hum Mol Genet 2010 Feb 19 3 434-44 Identification of a ferrochelatase mutation in a Chinese family with erythropoietic protoporphyria. Kong XF, Ye J, Gao DY, Gong QM, Zhang DH, Lu ZM, Lu YM, Zhang XX, J Hepatol 2008 Feb 48 2 375-9 Linkage between HLA-B8 and HLA-DQ2.5 contributes to ancestry-dependent risk for celiac disease. Long X, Karnati H, Ying W, Touma MJ, Smith I, Lewis SK, Xing C, Burstein E, Green PHR, Alkalay MJ, Bolze A, Kong XF, J Hum Immun 2026 Nov 2 6 The clinical utility of exome sequencing for risk stratification in celiac disease. Asif T, Akalay M, Chung WK, Green PHR, Kong XF, J Hum Immun 2026 Nov 2 6 e20260051 Results 1-10 of 43 1 2 3 4 5 Next Last Honors & Awards Clinical and Translational Science AwardThe Rockefeller University (2015) Jérôme Lejeune Foundation Award (2013) Stony Wold-Herbert Fund Award (2012) C.H. Li Memorial Scholar Award (2009) Keystone Symposia Travel Award (2009) First-Prize Scholarship,Shanghai Jiaotong University, School of Medicine (2004) Professional Associations/Affiliations American Association for the Study of Liver Diseases American Gastroenterological Association Clinical Immunology Society (2010) European Society for Immunodeficiencies (2012)